Tolerance, kinetics and depth of response for subcutaneous versus intravenous administration of bortezomib combination in Chinese newly diagnosed multiple myeloma patients

The retrospectively investigation compared the efficacy and safety of Bortezomib (Btz) administration via subcutaneous (SC) and intravenous (IV) in 307 newly-diagnosed multiple myeloma (NDMM) patients from a single Chinese center. SC Btz is associated with better tolerance. However, IV administratio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Xu, Yan, Deng, Shuhui, Mao, Xuehan, An, Gang, Li, Zengjun, Wang, Yafei, Fulciniti, Mariateresa, Ho, Matthew, Lin, Jianhong, Sui, Weiwei, Liu, Wei, Zou, Dehui, Yi, Shuhua, Huang, Wenyang, Liu, Hong, Lv, Rui, Li, Jian, Wang, Tingyu, Du, Chenxing, Munshi, Nikhil C, Qiu, Lugui
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5970050/
https://ncbi.nlm.nih.gov/pubmed/29625927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2018.03.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados